CVS Health
CVS
#150
Rank
$92.65 B
Marketcap
$72.14
Share price
1.39%
Change (1 day)
-26.19%
Change (1 year)

P/E ratio for CVS Health (CVS)

P/E ratio as of September 2023 (TTM): 30.9

According to CVS Health's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 30.9348. At the end of 2021 the company had a P/E ratio of 17.2.

P/E ratio history for CVS Health from 2001 to 2022

PE ratio at the end of each year

Year P/E ratio Change
202117.237.95%
202012.5-14.61%
201914.6-112.25%
2018-119-1164.75%
201711.2-29.96%
201616.0-23.7%
201520.9
201318.920.22%
201215.7

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-5.50-117.78%๐Ÿ‡บ๐Ÿ‡ธ USA
-68.2-320.35%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.0342-100.11%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.